A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: A randomized controlled trial

Journal of the Medical Association of Thailand

Volumn 89, Issue SUPPL. 4, 2006, Pages

  Ayudhaya, Orada Patamasingh Na ^a   Herabutya, Yongyoth ^a   Chanrachakul, Boonsri ^a   Ayuthaya, Nathpong Israngura Na ^a   O Prasertsawat, Pratak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Early pregnancy failure; Management; Misoprostol; Oral; Sublingual

Indexed keywords

MISOPROSTOL; PARACETAMOL; PETHIDINE;

ABDOMINAL PAIN; ABORTION; ADULT; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; EMBRYO DEATH; FEMALE; FEVER; GESTATIONAL AGE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ERROR; MENSTRUAL CYCLE; NAUSEA; PARITY; PREGNANCY DISORDER; PREGNANCY TERMINATION; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ADULT; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY COMPLICATIONS; TIME FACTORS;

EID: 33846652865     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. AlbermaE, Grudzinskas G, Chardt G. Spontaneous abortion: diagnosis and treatment. London: Springer-Verlag; 1992: 9-20.
2. Graziosi GMC, Mol BW, Ankun WM, Bruinse HW. Management of early pregnancy loss. Int J Gynaecol Obstet 2004; 86: 337-46.
3. Jurcovic C, Rose JA, Nicolaides KH. Expectant management of missed abortion. Br J Obstet Gynaecol 1998; 105: 670-1.
4. Nielsen S, Hahlin M. Expectant management of first trimester spontaneous abortion. Lancet 1995; 345: 84-6.
5. Ngai SW, Chan YM, Tang OS, Ho PC. Vaginal misoprostol as medical treatment of first trimester miscarriage. Human Reprod 2001; 16: 1493-6.
6. Tang OS, Soohweer H, Seyberth HW, Lee SW, Ho PG. Pharmacokinetics of different route of administration of misoprostol. Hum Reprod 2002; 17: 322-6.
7. Chong YS, Su LL, Arulkumaran S. Misoprostol: a quarter century of use, abuse and creative misuse. Obstet Gynecol Surv 2004; 59: 128-40.
8. Ho PC, Ngai SW, Lui KL, Won GCY, Lee SWH. Vaginal misoprostol compared with oral management in second trimester pregnancy. Obstet Gynecol Surv 1997; 90: 735-8.
9. Tang OS, Lau WN, Chan CW, Ho PC. A prospective randomized comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. Br J Obstet Gynaecol 2002; 111: 1001-5.
10. Tang OS, Miao BY, Lee SWH, Ho PC. Pilot study on the use of repeated doses of sublingual misoprostol in the termination of pregnancy up to 12 weeks of gestation. Hum Reprod 2002; 17: 1738-40.
11. Bernard KG, Cooperberg PL. Sonographic differentiation between blighted ovum and early viable pregnancy. Am J Roentgenol 1985; 144: 597-602.
12. Rulin MC, Bornstein SC, Campbell JD. The reliability of ultrasonography in the management of spontaneous abortion, clinically thought to be complete: a prospective study. Am J Obstet Gynecol 1993; 168: 12-5.
13. th ed. Connecticut: Appleton & Lange; 2005: 579-605.
14. Herabutya Y, O-Prasertsawat P, Pokpirom J. A comparison of intravaginal misoprostol and intracervical prostagandin E2 gel for ripening of unfavorable cervix and labor induction. J Obstet Gynaecol Res 1997; 3: 369-74.
15. Herabutya Y, O-Prasertsawat P. Misoprostol in the management of missed abortion. Int J Gynaecol Obstet 1997; 56: 263-6.
16. Herabutya Y, O-Prasertsawat P. Second trimester abortion using intravaginal misoprostol. Int J Gynaecol Obstet 1998; 60: 161-5.
17. Herabutya Y, Chanrachakul B, Punyavachira P. Vaginal misoprostol in termination of second trimester pregnancy. J Obstet Gynaecol Res 2000; 26: 121-5.
18. Herabutya Y, Chanrachakul B, Punyavachira P. Second trimester pregnancy termination: a comparison of 600 and 800 micrograms of intravaginal misoprostol. J Obstet Gynaecol Res 2001; 27: 125-8.
19. Herabutya Y, Chanrachakul B, Punyavachira P. Induction of labor with vaginal misoprostol for second trimester termination of pregnancy in the scarred uterus. Int J Gynaecol Obstet 2003; 83: 293-7.
20. Mitchell DC, Robert M, Richard G. Misoprostol for medical evacuation of early pregnancy failure. Obstet Gynecol Surv 1997; 89: 768-72.
21. Tang OS, Lau WNT, Yu H, Lee SW, Ho PC. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriage. Hum Reprod 2002: 20: 176-81.
22. Cheung W, Tang OS, Lee SW, Ho PC. Pilot study on the use of sublingual misoprostol in terminaton of pregnancy up to 7 weeks gestation. Contraception 2003; 68: 97-9.
23. Wagaarachchi P, Ashok P, Smith N, Templeton A. Medical management of early fetal demise using sublingual misoprostol. BJOG 2002; 109: 462-5.
24. Tang OS, Ong CY, Tse XY, Ng EH, Lee SW. A randomized trial to compare the use of sublingual misoprostol with or without additional 1 week course for management of first trimester silent miscarriage. Hum Reprod 2006; 21: 189-92.
25. Alcazar JL, Baldonado C, Larpatec C. The reliability of transvaginal ultrasonography to detect retained tissue after spontaneous first-trimester abortion, clinically thought to be complete. Ultrasound Obstet Gynaecol 1995; 6: 126-9.
26. Chung TK, Cheung L. Misoprostol in the management of spontaneous abortion. BJOG 1995; 102: 832-5.
27. Vimala N, Mittal S, Kumar S, Dadhwal V, Sharma Y. A randomized comparison of sublingual and vaginal misoprostol for cervical ripening before suction termination of first trimester pregnancy. Contraception 2004; 70: 117-20.
28. Chaff EA, Dicenzo RLS. Comparison of misoprostal plasma concentration following buccal and sublingual administration. Contraception 2005; 71: 22-5.
29. Todd C, Soler M, Castleman L, Roger M, Bluementhal P. Buccal misoprostol as cervical preparation for second trimester pregnancy termination. Contraception 2002; 65: 415-8.
30. Carlan S, Blust D, O'BrienW. Buccal versus intravaginal misoprostol administration for cervical ripening. Am J Obstet Gynecol 2002; 186: 229-33.